Page 18 - Revista SPORL - Vol 46. Nº3
P. 18

. M. Branco-Ferreira, et al


            14.  Marple B, Fornadley J, Patel A, et al. Keys to successful management of
               patients  with  allergic  rhinitis:  Focus  on  patient  confidence,  complian-
               ce, and satisfaction. American Academy of Otolaryngic Allergy Working
               Group on Allergic Rhinitis. Otolaryngol Head Neck Surg 2007;136 (6 Su-
               ppl):S107-24.
            15.  Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assess-
               ment of quality of life in patients with perennial allergic rhinitis with the
               French version of the SF-36 Health Status Questionnaire. J Allergy Clin
               Immmunol 1994;94:182-8.
            16.  Marshall PS, O’Hara C, Steinberg P. Effects of seasonal allergic rhinitis on
               selected cognitive abilities. Ann Allergy Asthma Immunol 2000;84:403-
               10.
            17.  Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep ap-
               nea. Am J Respir Crit Care Med 2002;165:1217-39.
            18.  Shedden A. Impact of nasal congestion on quality of life and work pro-
               ductivity in allergic rhinitis: findings from a large online survey. Treat Res-
               pir Med 2005;4:439-46.
            19.  Nathan  RA.  The  burden  of  allergic  rhinitis.  Allergy  Asthma  Proc
               2007;28:3-9.
            20.  Udaka T, Suzuki H, Fujimura T et al. Relationships between nasal obstruc-
               tion,  observed  apnea  and  daytime  sleepiness.  Otolaryngol  Head  Neck
               Surg 2007;137:669-73.
            21.  Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhini-
               tis: an independent risk factor for asthma in nonatopic subjects: results
               from the European Community Respiratory Health Survey. J Allergy Clin
               Immunol 1999;104:301-4.
            22.  Settipane RA, Lieberman P. Update on non-allergic rhinitis. Ann Allergy
               Asthma Immunol 2001;86:494-507.
            23.  Bachert C, van Cauwenberge P, Obrecht J, van Schoor J. Prevalence, clas-
               sification and perception of allergic and non-allergic rhinitis in Belgium.
               Allergy 2006;61:693-8.
            24.  Molgaard E, Thomsen SF, Lund T, Pedersen L, Nolte H, Backer V. Diffe-
               rences  between  allergic  and  non-allergic  rhinitis  in  a  large  sample  of
               adolescents and adults. Allergy 2007;62:1033-7.
            25.  Long AA. Findings from a 1000-patient Internet-based survey assessing
               the impact of morning symptoms on individuals with allergic rhinitis. Clin
               Ther 2007;29:342-51.
            26.  Stull DE, Krouse J, Meltzer EO, et al. Development and validation of the
               Congestion Quantifier Seven-Item test (CQ7): A screening tool for nasal
               congestion. Value Health 2007;10:457-65.
            27.  Brämerson A, Johnsson L, Ek L, Nordin S, Bende M. Prevalence of ol-
               factory dysfunction: the Skövde population-based study. Laryngoscope
               2004;114:733-7.
            28.  Gudziol V, Lötsch J, Hähner A, Zahnert T, Hummel T. Clinical significance
               of results from olfactory testing. Laryngoscope 2006;116:1858-63.
            29.  Blomqvist EH, Brämerson A, Stjärne P, Nordin S. Consequences of olfac-
               tory loss and adopted coping strategies. Rhinology 2004;42:189-94.
            30.  Bousquet PJ, Combescure C, Neukirch F et al. Visual analog scales can
               assess the severity or rhinitis graded according to ARIA guidelines. Aller-
               gy 2007;62:367-72.
            31.  Reed SD, Lee TA, McCrory DC. The economic burden of allergic rhinitis: a
               critical evaluation of the literature. Pharmacoeconomics 2004;22:345-61.
            32.  Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc 2007;28:
               3-9.
            33.  Akerlund  A,  Millqvist  E,  Oberg  D,  Bende  M.  Prevalence  of  upper  and
               lower airway symptoms: the Skövde population-based study. Acta Oto-
               laryngol 2006;126:483-8.
            34.  Philpott  CM,  El-Alami  M,  Murty  GE.  The  effect  of  steroid  sex  hormo-
               nes on the nasal airway during normal menstrual cycle. Clin Otolaryngol
               Allied Sci 2004;29:138-42.
            35.  Fraga S, Sousa S, Santos AC, et al. Tabagismo em Portugal. Arq Med
               2005;19:207-29.
            36. www.insarj.pt/site/insa_notevento_01.asp?noticia=1&artigo_id=214.
            37.  Bozec A, Guevara N, Bailleux S, Lecoq M, Santini J, Castillo L. Evaluation
               of  rhinologic  signs  among  smokers.  Ann  Otolaryngol  Chir  Cervicofac
               2004;121:286-91.
            38.  Virkkula P, Hytönen M, Bachour A, et al. Smoking and improvement after
               nasal surgery in snoring men. Am J Rhinol 2007;21:169-73.
            39.  De S, Fenton JE, Jones AS, Clark RW. Passive smoking, allergic rhinitis and
               nasal obstruction in children. J Laryngol Otol 2005;119:955-7.
            40.  Asahi S, Uehara R, Watanabe M, et al. Respiratory symptoms correlating
               to smoking prevalence: the National Nutrition Survey and the National
               Lifestyle Survey in Japan. J Epidemiol 2003;13:226-31.





        160 REVISTA PORTUGUESA DE OTORRINOLARINGOLOGIA E CIRURGIA CÉRVICO-FACIAL


      SPORL SET 08.indd   160                                                                             08/10/20   15:51:40
   13   14   15   16   17   18   19   20   21   22   23